- Home
- DTST vs PMN Comparison
DTST vs PMN Comparison
Compare DTST & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTST | PMN |
|---|---|---|
| Founded | 2001 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6M | 23.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DTST | PMN |
|---|---|---|
| Price | $5.00 | $8.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $72.67 |
| AVG Volume (30 Days) | ★ 134.9K | 43.4K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8036.56 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $25,529,819.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.29 | ★ N/A |
| Revenue Growth | ★ 260.19 | N/A |
| 52 Week Low | $2.93 | $6.27 |
| 52 Week High | $5.44 | $39.75 |
Technical Indicators
Market Signals| Indicator | DTST | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 76.90 | 88.71 |
| Support Level | $4.93 | $7.35 |
| Resistance Level | $5.05 | $9.26 |
| Average True Range (ATR) | 0.13 | 0.60 |
| MACD | 0.08 | 0.43 |
| Stochastic Oscillator | 94.29 | 96.99 |
Price Performance
Historical ComparisonAbout DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.